XML 43 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Capital Structure
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Capital Structure

NOTE 8 – CAPITAL STRUCTURE

 

At the Company’s Special Shareholders Meeting held in December 2019, a number of proposals were presented and passed by the Company’s shareholders, including Proposal 1 to increase the number of authorized shares of Class A Shares of the Company, par value $0.0001 per share (“Class A Shares”), from 300,000,000 to 500,000,000, (such amendment, “Amendment No. 1”); Proposal 2 to change the name of the Company’s Class A Shares from “Class A” to “common stock” (“common stock” or “Common Stock”),with the same $0.0001 par value per share, designations, powers, privileges, rights, qualifications, limitations, and restrictions as the former Class A Shares, and Proposal 3 to eliminate Class B Shares as a class of capital stock of the Company. All references to Common Stock described herein below include by definition any former Class A common stock.

 

Accordingly, the Company is now authorized to issue 500,000,000 shares of Common Stock with a par value of $.0001 per share, with each share having one voting right.

 

Common Stock

 

At March 31, 2020, there were 310,473,284 total shares of Common Stock outstanding.

 

During the three-months ended March 31, 2020, the Company: issued 13,824,607 shares of Rule 144 restricted Common Stock, including 600,000 shares issued in a private placement to an accredited investor, at $0.10 per share, 3,906,610 for the conversion of a prior loan at $0.047 per shares, 1,460,260 shares for costs related to the issuance of promissory notes at an average $0.085 per share and 857,737 shares at $0.01 per share from convertible warrants conversions. Shares to be issued are for the settlement of legal expenses which were accrued pursuant to agreements with two prior law firms.

 

During the three-months ended March 31, 2019, the Company issued 766,667 shares of restricted Common Stock to three (3) individuals holding warrants for costs related to the issuance of promissory notes of 366,667, 200,000 and 200,000 shares respectively, priced at $0.01/converted share.

 

At December 31, 2019, there were 296,648,677 shares of Common Stock outstanding.

 

Class B Stock

 

At March 31, 2020, there are no longer any Class B shares, as such shares were terminated in December 2019. For the same period ending March 31, 2019, there were no shares of Class B stock issued and outstanding.

 

Stock options, warrants and other rights

 

As of March 31, 2020 and 2019 respectively, the Company has not adopted and does not have an employee stock option plan.

 

As of March 31, 2020, the Company had total warrants issued and outstanding of 8,000,000, with current remaining expiration periods of less than one year, including 4,000,000 warrants in favor of Reynolds expiring in October 2020, and 4,000,000 warrants in favor of Harer expiring in January 2021. The weighted average exercise price of these remaining warrants is $.175, with remaining terms of less than a year.

 

At the year ended December 2019, the Company had 10,857,737 warrants outstanding, of which 2,000,000 expired in February 2020, and 857,737 were converted into restricted common stock in the period ended March 2020. The original warrants were issued for loan costs related to Mabert loans made in December 2018. The Company recorded a debt discount of $68,619 at the issuance of the loan, such amount fully amortized through December 2109, and recorded a subscription receivable of $8,577 for the cost to the shareholder of the warrant at conversion.